Aperio Group LLC boosted its position in Tenet Healthcare Corporation (NYSE:THC) by 67.3% during the second quarter, Holdings Channel reports. The firm owned 81,276 shares of the company’s stock after buying an additional 32,708 shares during the period. Aperio Group LLC’s holdings in Tenet Healthcare Corporation were worth $1,572,000 at the end of the most recent reporting period.
Other hedge funds have also recently bought and sold shares of the company. Harris Associates L P raised its stake in Tenet Healthcare Corporation by 2.2% in the first quarter. Harris Associates L P now owns 7,625,365 shares of the company’s stock worth $135,046,000 after buying an additional 166,100 shares during the period. Vanguard Group Inc. raised its stake in Tenet Healthcare Corporation by 2.5% in the first quarter. Vanguard Group Inc. now owns 6,587,359 shares of the company’s stock worth $116,662,000 after buying an additional 160,814 shares during the period. FMR LLC raised its stake in Tenet Healthcare Corporation by 6.2% in the first quarter. FMR LLC now owns 2,720,013 shares of the company’s stock worth $48,171,000 after buying an additional 159,700 shares during the period. State Street Corp raised its stake in Tenet Healthcare Corporation by 1.2% in the first quarter. State Street Corp now owns 2,333,013 shares of the company’s stock worth $41,316,000 after buying an additional 27,898 shares during the period. Finally, North Tide Capital LLC bought a new position in shares of Tenet Healthcare Corporation during the first quarter worth approximately $35,420,000.
Tenet Healthcare Corporation (NYSE THC) traded up 5.00% during trading on Friday, hitting $14.06. 4,308,396 shares of the stock were exchanged. Tenet Healthcare Corporation has a 12 month low of $13.21 and a 12 month high of $25.96. The stock’s market cap is $1.42 billion. The stock’s 50 day moving average price is $18.34 and its 200 day moving average price is $18.07.
Tenet Healthcare Corporation (NYSE:THC) last announced its quarterly earnings data on Monday, August 7th. The company reported ($0.17) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.17). Tenet Healthcare Corporation had a negative net margin of 0.97% and a negative return on equity of 2.00%. The company had revenue of $14.80 billion for the quarter, compared to the consensus estimate of $4.90 billion. During the same period in the prior year, the firm posted $0.38 EPS. The company’s quarterly revenue was up 204.1% compared to the same quarter last year. Analysts forecast that Tenet Healthcare Corporation will post $0.83 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Tenet Healthcare Corporation (THC) Stake Raised by Aperio Group LLC” was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another domain, it was stolen and republished in violation of United States & international copyright & trademark laws. The correct version of this story can be accessed at https://www.tickerreport.com/banking-finance/2802113/tenet-healthcare-corporation-thc-stake-raised-by-aperio-group-llc.html.
A number of brokerages have recently commented on THC. Citigroup Inc. reaffirmed a “neutral” rating and set a $16.00 target price (down from $20.00) on shares of Tenet Healthcare Corporation in a research report on Thursday. Deutsche Bank AG reaffirmed a “buy” rating and set a $24.00 target price (down from $28.00) on shares of Tenet Healthcare Corporation in a research report on Thursday. Jefferies Group LLC reaffirmed a “buy” rating and set a $24.00 target price (down from $26.00) on shares of Tenet Healthcare Corporation in a research report on Tuesday. Robert W. Baird reaffirmed an “outperform” rating and set a $23.00 target price on shares of Tenet Healthcare Corporation in a research report on Thursday. Finally, BidaskClub lowered shares of Tenet Healthcare Corporation from a “hold” rating to a “sell” rating in a research report on Saturday, August 5th. Three analysts have rated the stock with a sell rating, nine have given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Tenet Healthcare Corporation presently has a consensus rating of “Hold” and a consensus price target of $22.67.
About Tenet Healthcare Corporation
Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC).
Receive News & Ratings for Tenet Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.